CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy

Journal of Hepatology

Volumn 64, Issue 1, 2016, Pages 160-170

  Zhang, Xiang ^a   Han, Juqiang ^a,b   Man, Kwan ^c   Li, Xiaoxing ^a,d   Du, Jinghua ^a,e   Chu, Eagle S H ^a   Go, Minnie Y Y ^a   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^e HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Autophagy; CXCR3; Macrophage; Non alcoholic steatohepatitis

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CHOLINE; CXCL3 CHEMOKINE; GLUCOSE REGULATED PROTEIN 78; INITIATION FACTOR 2; METHIONINE; PROTEIN P62; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, HUMAN; CXCR3 PROTEIN, MOUSE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL INFILTRATION; CHOLESTEROL DIET; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER CELL DAMAGE; LIVER FIBROSIS; MACROPHAGE; MALE; MIDDLE AGED; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; DEFICIENCY; IMMUNOLOGY; LIPOGENESIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY; VITAMIN DEFICIENCY;

ANIMALS; AUTOPHAGY; CHOLINE DEFICIENCY; CYTOKINES; ENDOPLASMIC RETICULUM STRESS; HUMANS; LIPOGENESIS; MACROPHAGES; MALE; METHIONINE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NON-ALCOHOLIC FATTY LIVER DISEASE; RECEPTORS, CXCR3; TH1 CELLS; TH17 CELLS;

EID: 84961795060     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.09.005     Document Type: Article

References (54)

1. M.L. Berres, A. Nellen, and H.E. Wasmuth Chemokines as immune mediators of liver diseases related to the metabolic syndrome Dig Dis 28 2010 192 196
2. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 S99 S112
3. C. Carter-Kent, N.N. Zein, and A.E. Feldstein Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment Am J Gastroenterol 103 2008 1036 1042
4. R. Horuk Chemokine receptor antagonists: overcoming developmental hurdles Nat Rev Drug Discov 8 2009 23 33
5. H.E. Wasmuth, F. Lammert, M.M. Zaldivar, R. Weiskirchen, C. Hellerbrand, D. Scholten, and et al. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans Gastroenterology 137 2009 309 319 319, e301-e303
6. H.E. Wasmuth, F. Tacke, and C. Trautwein Chemokines in liver inflammation and fibrosis Semin Liver Dis 30 2010 215 225
7. M. Krauthausen, M.P. Kummer, J. Zimmermann, E. Reyes-Irisarri, D. Terwel, B. Bulic, and et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model J Clin Invest 125 2015 365 378
8. S. Qin, J.B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, and et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 1998 746 754
9. J. Zhou, P.C. Tang, L. Qin, P.M. Gayed, W. Li, E.A. Skokos, and et al. CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses J Exp Med 207 2010 1951 1966
10. J.A. Deiuliis, S. Oghumu, D. Duggineni, J. Zhong, J. Rutsky, A. Banerjee, and et al. CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance Obesity (Silver Spring) 22 2014 1264 1274
11. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
12. X. Zhang, J. Shen, K. Man, E.S. Chu, T.O. Yau, J.C. Sung, and et al. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis J Hepatol 61 2014 1365 1375
13. W.W. Hancock, B. Lu, W. Gao, V. Csizmadia, K. Faia, J.A. King, and et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection J Exp Med 192 2000 1515 1520
14. J. Yu, E.S. Chu, R. Wang, S. Wang, C.W. Wu, V.W. Wong, and et al. Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice Gastroenterology 138 2010 694 704 704, e691
15. R. Kohli, M. Kirby, S.A. Xanthakos, S. Softic, A.E. Feldstein, V. Saxena, and et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis Hepatology 52 2010 934 944
16. T.C. Walser, S. Rifat, X. Ma, N. Kundu, C. Ward, O. Goloubeva, and et al. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer Cancer Res 66 2006 7701 7707
17. C.H. Jenh, M.A. Cox, L. Cui, E.P. Reich, L. Sullivan, S.C. Chen, and et al. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection BMC Immunol 13 2012 2
18. Z.B. Deng, Y. Liu, C. Liu, X. Xiang, J. Wang, Z. Cheng, and et al. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation Hepatology 50 2009 1412 1420
19. R.G. Baker, M.S. Hayden, and S. Ghosh NF-kappaB, inflammation, and metabolic disease Cell Metab 13 2011 11 22
20. S. Oghumu, S. Varikuti, C. Terrazas, D. Kotov, M.W. Nasser, C.A. Powell, and et al. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model Immunology 143 2014 109 119
21. S.U. Amano, J.L. Cohen, P. Vangala, M. Tencerova, S.M. Nicoloro, J.C. Yawe, and et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation Cell Metab 19 2014 162 171
22. F. Marra, and F. Tacke Roles for chemokines in liver disease Gastroenterology 147 2014 577 594
23. Y.H. Oo, V. Banz, D. Kavanagh, E. Liaskou, D.R. Withers, E. Humphreys, and et al. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver J Hepatol 57 2012 1044 1051
24. Y. Zhu, D. Vergote, C. Pardo, F. Noorbakhsh, J.C. McArthur, M.D. Hollenberg, and et al. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy FASEB J 23 2009 2928 2941
25. M. Balan, and S. Pal A novel CXCR3-B-induced growth-inhibitory signal in cancer cells is mediated through the regulations of Bach-1 and Nrf2 nuclear translocation J Biol Chem 289 2014 3126 3137
26. D.J. Klionsky, H. Abeliovich, P. Agostinis, D.K. Agrawal, G. Aliev, D.S. Askew, and et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes Autophagy 4 2008 151 175
27. R. Mathew, C.M. Karp, B. Beaudoin, N. Vuong, G. Chen, H.Y. Chen, and et al. Autophagy suppresses tumorigenesis through elimination of p62 Cell 137 2009 1062 1075
28. E.L. Eskelinen Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy Mol Aspects Med 27 2006 495 502
29. X.J. Wang, J. Yu, S.H. Wong, A.S. Cheng, F.K. Chan, S.S. Ng, and et al. A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy Autophagy 9 2013 1500 1508
30. M.E. Rinella, M.S. Siddiqui, K. Gardikiotes, J. Gottstein, M. Elias, and R.M. Green Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis Hepatology 54 2011 1600 1609
31. M. Kato, C. Ospelt, R.E. Gay, S. Gay, and K. Klein Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts Arthritis Rheumatol 66 2014 40 48
32. H. Sahin, E. Borkham-Kamphorst, C. Kuppe, M.M. Zaldivar, C. Grouls, M. Al-samman, and et al. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice Hepatology 55 2012 1610 1619
33. M. Zeremski, L.M. Petrovic, L. Chiriboga, Q.B. Brown, H.T. Yee, M. Kinkhabwala, and et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C Hepatology 48 2008 1440 1450
34. S. Lacotte, S. Brun, S. Muller, and H. Dumortier CXCR3, inflammation, and autoimmune diseases Ann N Y Acad Sci 1173 2009 310 317
35. B. Shen, J. Yu, S. Wang, E.S. Chu, V.W. Wong, X. Zhou, and et al. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo Hepatology 47 2008 473 483
36. J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, and et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
37. B. Zhang, J. Patel, M. Croyle, M.S. Diamond, and R.S. Klein TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis J Neuroimmunol 224 2010 28 38
38. K.J. Helbig, A. Ruszkiewicz, R.E. Lanford, M.D. Berzsenyi, H.A. Harley, S.R. McColl, and et al. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro J Virol 83 2009 836 846
39. G.C. Farrell, D. van Rooyen, L. Gan, and S. Chitturi NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications Gut Liver 6 2012 149 171
40. V.Z. Rocha, E.J. Folco, C. Ozdemir, Y. Sheikine, T. Christen, G.K. Sukhova, and et al. CXCR3 controls T-cell accumulation in fat inflammation Arterioscler Thromb Vasc Biol 34 2014 1374 1381
41. Y. Kakuta, M. Okumi, S. Miyagawa, K. Tsutahara, T. Abe, K. Yazawa, and et al. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection Transplantation 93 2012 24 31
42. C.W. Wu, E.S. Chu, C.N. Lam, A.S. Cheng, C.W. Lee, V.W. Wong, and et al. PPARgamma is essential for protection against nonalcoholic steatohepatitis Gene Ther 17 2010 790 798
43. Y. Liu, K. Qiu de, and X. Ma Liver X receptors bridge hepatic lipid metabolism and inflammation J Dig Dis 13 2012 69 74
44. M.J. Czaja Functions of autophagy in hepatic and pancreatic physiology and disease Gastroenterology 140 2011 1895 1908
45. D. Ma, M.M. Molusky, J. Song, C.R. Hu, F. Fang, C. Rui, and et al. Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD Mol Endocrinol 27 2013 1643 1654
46. S. Pankiv, T.H. Clausen, T. Lamark, A. Brech, J.A. Bruun, H. Outzen, and et al. P62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy J Biol Chem 282 2007 24131 24145
47. M. Komatsu, S. Waguri, M. Koike, Y.S. Sou, T. Ueno, T. Hara, and et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice Cell 131 2007 1149 1163
48. V.I. Korolchuk, F.M. Menzies, and D.C. Rubinsztein A novel link between autophagy and the ubiquitin-proteasome system Autophagy 5 2009 862 863
49. A. Meiser, A. Mueller, E.L. Wise, E.M. McDonagh, S.J. Petit, N. Saran, and et al. The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor J Immunol 180 2008 6713 6724
50. H. Su, and X. Wang P62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress Trends Cardiovasc Med 21 2011 224 228
51. J.A. Deiuliis, S. Oghumu, D. Duggineni, J. Zhong, J. Rutsky, A. Banerjee, and et al. CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance Obesity (Silver Spring) 22 2014 1264 1274
52. Y. Zhai, X.D. Shen, W.W. Hancock, F. Gao, B. Qiao, C. Lassman, and et al. CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury J Immunol 176 2006 6313 6322
53. H. Weng, P.R. Mertens, A.M. Gressner, and S. Dooley IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads J Hepatol 46 2007 295 303
54. M.M. Zaldivar, M.L. Berres, H. Sahin, A. Nellen, D. Heinrichs, P. Schmitz, and et al. The chemokine receptor CXCR3 limits injury after acute toxic liver damage Lab Invest 92 2012 724 734